Key Insights

Highlights

Treatment Research

2 treatments under study, led by Control Group

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown1

Clinical Trials (1)

Research Network

Common Treatments

  • Control Group1
  • Cervix Dilated After Surgery1

Active Sponsors

  • Bakirkoy Dr. Sadi Konuk Research and Training Hospital1

Top Investigators

Related Conditions

  • Complications Cesarean Section1
  • External Causes Of Morbidity And Mortality1
  • Wound Infection1

Activity Timeline